Skip to main content

Ghost Tree Capital, LLC

SEC CIK
0001595851
Latest filing
Nov 14, 2024

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Ghost Tree Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q3 2024 holdings

Shares (Q3 2024)
150,000
Value
$7.67M
% of portfolio
2.6%
Quarters held
9
Since Q2 2021
Holdings of CRNX by Ghost Tree Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 2024150,000$7.67M2.6%−90,000−37.5%ReducedHolders
Q2 2024240,000$10.7M3.7%+40,000+20.0%AddedHolders
Q1 2024200,000$9.36M3.0%+135,000+207.7%AddedHolders
Q4 202365,000$2.31M1.3%−36,443−35.9%ReducedHolders
Q3 2023101,443$3.02M1.5%+101,443NewHolders
Q2 20220$00.0%−85,000−100.0%Sold outHolders
Q1 202285,000$1.87M0.9%−33,344−28.2%ReducedHolders
Q4 2021118,344$3.36M1.3%−31,656−21.1%ReducedHolders
Q3 2021150,000$3.16M1.0%−93,309−38.3%ReducedHolders
Q2 2021243,309$4.59M1.4%+243,309NewHolders